The company was established in Europe in Belgium. The main office of represented VC is situated in the Angleur.
Among the most popular fund investment industries, there are Therapeutics, Health Care. Among the most popular portfolio startups of the fund, we may highlight DIM3, Okapi Sciences, Convert Pharmaceuticals. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Spinventure, startups are often financed by Spreds, Meusinvest, Inventures SA. The meaningful sponsors for the fund in investment in the same round are Spreds, Meusinvest, Inventures SA. In the next rounds fund is usually obtained by Walloon, The Institute for the Promotion of Innovation by Science and Technology in Flanders.
This Spinventure works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2014.
Related Funds
Fund Name | Location |
Beijing Beilu Pharmaceutical | Beijing, Beijing, China |
Blue Ventures | England, London, United Kingdom |
Dragon Wings Capital | Beijing, Beijing, China |
GAA Investments | Florida, United States, Weston |
Hummingbird Ventures | Belgium, Gent, Oost-Vlaanderen |
iFund | Japan, Tokyo |
KDG | Beijing, Beijing, China |
LD Capital | China, Shanghai, Shanghai |
Liby Group | China, Guangdong, Guangzhou |
Ludwig s.r.l. | - |
Lufthansa Cargo | Frankfurt, Germany, Hessen |
MAGIX | Nevada, Reno, United States |
Moraun Investments | Luxembourg, Luxembourg |
Net Fund Europe | - |
RGB Capital | California, San Diego, United States |
Technology 9 Labs (T9L) | Delhi, India, New Delhi |
Toread Holdings Group | Beijing, Changping, China |
WaterBridge Ventures | Delhi, India, New Delhi |
ZMC | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Convert Pharmaceuticals | $16M | 28 Feb 2018 | Liège, Liège, Belgium | ||
vitricell | $840K | 23 Jan 2018 | Wisconsin, United States | ||
Elysia | $1M | 30 Jun 2015 | Liège, Liège, Belgium | ||
2-Observe | $826K | 17 Jun 2015 | Belgium, Liège | ||
Okapi Sciences | $10M | 03 Nov 2008 | Belgium, Flemish Brabant |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Convert Pharmaceuticals | $16M | 28 Feb 2018 | Liège, Liège, Belgium | ||
vitricell | $840K | 23 Jan 2018 | Wisconsin, United States | ||
Elysia | $1M | 30 Jun 2015 | Liège, Liège, Belgium | ||
2-Observe | $826K | 17 Jun 2015 | Belgium, Liège | ||
Okapi Sciences | $10M | 03 Nov 2008 | Belgium, Flemish Brabant |